Tuesday, 15 Oct 2019

Drug Safety

Datesort ascending Type Title Save
14 Oct 2019 News Hydroxychloroquine Blood Levels May Predict Future Retinopathy
12 Oct 2019 Social RheumNow Podcast is up! When you're hot you're hot! Watch it on youtube>> https://t.co/GlqMzjUnhE or listen to the podcast on iTues, Apple podcast or on Stitcher or SoundCloud>> https://t.co/a1zE7VXtog
07 Oct 2019 Social The RheumNow Podcast is up! Women are Taking Over Rheumatology. Watch is on the website>> https://t.co/YuDVm1lLXZ or listen to thoe podcast on iTunes, Stitcher, Overcast or SoundCloud >> https://t.co/A8FzdUaEk2
03 Oct 2019 Social Might Vioxx make a backdoor comeback? 2017 Vioxx went off patent, now a small pharma has applied to the FDA for orphan drug approval of rofecoxib (& etoricoxib) to treat hemophiliac arthropathy (large unmet need). Say it aint so! https://t.co/kENHHhcyIT https://t.co/QpDNiaCZyz
02 Oct 2019 Social Analysis of retail pharmacies and drug costs show that, compared to large chain pharmacies, big box was 48% cheaper, followed by grocery-based (18% cheaper), next small chain (51% higher), and independent pharmacies (61% higher) https://t.co/jlQnNboiAR
29 Sep 2019 Social The RheumNow Podcast is up - Watch it here>> https://t.co/PolTYQqbBW or listen to the podcast on iTunes, or SoundCloud>> https://t.co/ILQQw2kpse
24 Sep 2019 News Arthritis Foundation Releases First CBD Guidance for Adults With Arthritis
23 Sep 2019 News Persistent Inflammatory Arthritis After Immune Checkpoint Inhibitors
23 Sep 2019 Social FDA issues warning against the use of higher doses of Imodium (loperamide) - has been associated with "serious heart problems and deaths with much higher than the recommended doses of loperamide". https://t.co/UxPn6F6BL0
22 Sep 2019 Social The RheumNow Podcast is up – Vitamin D or Rituximab- Belive it or not? Watch it on RheumNow>> https://t.co/bX5u9KcKYz or listen to the podcast on iTunes or SoundCloud>> https://t.co/MxDcIyej3L
18 Sep 2019 Social RT @psufka: This podcast is a must listen for anyone in healthcare. https://t.co/q5Oociau7r
15 Sep 2019 Social The End of Arthritis - a RheumNow Podcast is up. See it here> https://t.co/lzqUWFDRB3 or listen to the podcast on iTunes or SoundCloud> https://t.co/M1DfgZwtzT
28 Aug 2019 Social RT @dcmarbury: Wow. Just wow. This is frigging terrible. How has this flown under the radar for so long? #greed #corruption #pbms #terri…
28 Aug 2019 News Checkpoint Inhibitors: Who Gets Myocarditis?
14 Aug 2019 Social Kaiser study from N California shows increasing trend in cannabis use w/ #pregnancy. Sample of 367 403 pregnancies in 276 991 women between 2009-18, cannibis use rose from 1.95% to 3.38% - ?increasing acceptance & decreasing perceptions of harms? https://t.co/VdOPrCsZQ1
12 Aug 2019 Slide of the day CANTOS vs. CIRT Trial Comparison
09 Aug 2019 News NSAIDs Mediate Cardiovascular Risk in OA
05 Aug 2019 Social Claims analysis of f 45,208 TNFi +MTX initiators and 1,387 triple DMARD (MSH) initiators showed no significant difference in the risk of serious infections (2.46 TNFi+MTX vs 2.03 triple DMARD/100PY) (HR 1.23; 0.87‐1.74) https://t.co/pe52p8Xtrv
29 Jul 2019 Social Testosterone replacement therapy Increases the risk of CV events (MI/CVA/TIA). Study of 15,401 men, >45 yrs old, w/ low testosterone & no evidence of hypogonadotropic or testicular dz (1995-2017). HR 1.21; CI 1.0-1.46), highest in the 1st 2yrs https://t.co/nNXyFIo1EH
28 Jul 2019 Social Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted a negative opinion on Application for romosozumab (Evenity) for the treatment of severe osteoporosis (by Amgen & UCB); an appeal is planned https://t.co/EVjxuBQdF0